These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 17719757

  • 1. Urinary metabolic fingerprinting for amiodarone-induced phospholipidosis in rats using FT-ICR MS.
    Hasegawa M, Takenaka S, Kuwamura M, Yamate J, Tsuyama S.
    Exp Toxicol Pathol; 2007 Oct; 59(2):115-20. PubMed ID: 17719757
    [Abstract] [Full Text] [Related]

  • 2. Biomarkers to monitor drug-induced phospholipidosis.
    Baronas ET, Lee JW, Alden C, Hsieh FY.
    Toxicol Appl Pharmacol; 2007 Jan 01; 218(1):72-8. PubMed ID: 17156806
    [Abstract] [Full Text] [Related]

  • 3. Urinary metabolic fingerprinting for alpha-naphthylisothiocyanate-induced intrahepatic cholestasis in rats using Fourier transform-ion cyclotron resonance mass spectrometry.
    Hasegawa M, Ide M, Fujita T, Takenaka S.
    Toxicol Pathol; 2008 Oct 01; 36(6):818-26. PubMed ID: 18776161
    [Abstract] [Full Text] [Related]

  • 4. Relationship between in vitro phospholipidosis assay using HepG2 cells and 2-week toxicity studies in rats.
    Miyamoto S, Matsumoto A, Mori I, Horinouchi A.
    Toxicol Mech Methods; 2009 Oct 01; 19(8):477-85. PubMed ID: 19793005
    [Abstract] [Full Text] [Related]

  • 5. Urinary metabolic fingerprinting for thioacetamide-induced rat acute hepatic injury using fourier transform-ion cyclotron resonance mass spectrometry (FT-ICR MS), with reference to detection of potential biomarkers for hepatotoxicity.
    Hasegawa M, Ide M, Takenaka S, Yamate J, Tsuyama S.
    Toxicol Pathol; 2007 Jun 01; 35(4):570-5. PubMed ID: 17715493
    [Abstract] [Full Text] [Related]

  • 6. Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.
    Tilmant K, Gerets HH, Dhalluin S, Hanon E, Depelchin O, Cossu-Leguille C, Vasseur P, Atienzar FA.
    Toxicol In Vitro; 2011 Oct 01; 25(7):1414-24. PubMed ID: 21515356
    [Abstract] [Full Text] [Related]

  • 7. Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development.
    Fujimura H, Dekura E, Kurabe M, Shimazu N, Koitabashi M, Toriumi W.
    Exp Toxicol Pathol; 2007 Aug 01; 58(6):375-82. PubMed ID: 17408938
    [Abstract] [Full Text] [Related]

  • 8. Phospholipidosis in rats treated with amiodarone: serum biochemistry and whole genome micro-array analysis supporting the lipid traffic jam hypothesis and the subsequent rise of the biomarker BMP.
    Mesens N, Desmidt M, Verheyen GR, Starckx S, Damsch S, De Vries R, Verhemeldonck M, Van Gompel J, Lampo A, Lammens L.
    Toxicol Pathol; 2012 Apr 01; 40(3):491-503. PubMed ID: 22291062
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular biomarkers of phospholipidosis in rat blood and heart after amiodarone treatment.
    Bocchini N, Giantin M, Crivellente F, Ferraresso S, Faustinelli I, Dacasto M, Cristofori P.
    J Appl Toxicol; 2015 Jan 01; 35(1):90-103. PubMed ID: 25580480
    [Abstract] [Full Text] [Related]

  • 11. In vitro assays and biomarkers for drug-induced phospholipidosis.
    Monteith DK, Morgan RE, Halstead B.
    Expert Opin Drug Metab Toxicol; 2006 Oct 01; 2(5):687-96. PubMed ID: 17014389
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Structural analysis of monoterpene glycosides extracted from Paeonia lactiflora Pall. using electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry and high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Dong H, Liu Z, Song F, Yu Z, Li H, Liu S.
    Rapid Commun Mass Spectrom; 2007 Oct 01; 21(19):3193-9. PubMed ID: 17764105
    [Abstract] [Full Text] [Related]

  • 15. Phenylacetylglycine, a putative biomarker of phospholipidosis: its origins and relevance to phospholipid accumulation using amiodarone treated rats as a model.
    Delaney J, Neville WA, Swain A, Miles A, Leonard MS, Waterfield CJ.
    Biomarkers; 2004 Oct 01; 9(3):271-90. PubMed ID: 15764292
    [Abstract] [Full Text] [Related]

  • 16. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
    Martin WJ, Standing JE.
    J Pharmacol Exp Ther; 1988 Feb 01; 244(2):774-9. PubMed ID: 3346847
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biomarkers of furan exposure by metabolic profiling of rat urine with liquid chromatography-tandem mass spectrometry and principal component analysis.
    Kellert M, Wagner S, Lutz U, Lutz WK.
    Chem Res Toxicol; 2008 Mar 01; 21(3):761-8. PubMed ID: 18269250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.